The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EBMT 2022 | Preventing and managing post-transplant complications in multiple myeloma
Meral Beksac, MD, Ankara University, Ankara, Turkey, outlines strategies to avoid and manage post-transplant complications in multiple myeloma. Dr Beksac explains that frailty and comorbidities, as well as the choice of induction regimen prior to autologous transplantation all play a role in the incidence of complications post-transplant. In addition, it might be beneficial to reduce the conditioning intensity in some patients to avoid complications. In high-risk patients, it may also be necessary to initiate consolidation therapy earlier to prevent disease progression. This interview took place at the 48th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2022, which was held virtually.
